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ABSTRACT
Background  and  Objectives:  Presence  of  methicillin  and  multidrug  resistance  has  associated  coagulase  negative 
staphylococci  (CNS)  with  high  morbidity  and  mortality  worldwide.  The  present  study  was  carried  out  to  study  the 
susceptibility pattern of CNS to various antimicrobial agents and to determine the prevalence of CNS methicillin resistance 
in our hospital setting.
Materials and Methods:  A total of 300 strains of CNS isolated from various clinical specimens were subjected to speciation 
and their antimicrobial sensitivity testing was studied by Kirby Bauer disc diffusion method. Methicillin resistance was 
studied by observing minimum inhibitory concentration (MIC) of Oxacillin by macrobroth dilution method and E test. 
Susceptibility to vancomycin was determined by vancomycin screen agar test and minimum inhibitory concentration by 
macrobroth dilution test.
Results: All the isolates were susceptible to vancomycin, linezolid and teicoplanin in disc diffusion test while maximum 
resistance was noted against penicillin (100%) followed by ciprofloxacin (36.3%), norfloxacin (34.3%), gentamicin (34%), 
nitrofurantoin (29.9%), erythromycin (27.9%) and amikacin (22.7%). Fifty two percent (n = 156) of the isolates were found 
to be resistant to methicillin. A comparison between resistance patterns of methicilin resistant and methicillin sensitive 
strains showed that methicillin resistant isolates had higher level of resistance to other antibiotics.
Conclusions: The  high level of resistance among CNS  to commonly used antimicrobial agents in our hospital is a matter of 
great concern and can be prevented by practices of effective infection control measures.
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INTRODUCTION
Though  a  part  of  normal  cutaneous  ecosystem, 
coagulase  negative  staphylococci  (CNS)  have 
assumed a great pathogenic potential and are being 
recognized  as  important  agents  of  nosocomial 
infection (1). These organisms express resistance to 
multiple antibiotics  which  not  only  pose  a  serious 
therapeutic  problem  but  also  serve  as  a  hospital 
reservoir of antibiotic resistance genes. An increase 
in incidence of nosocomial infections caused by CNS 
which are resistant to methicillin (MRCNS) and other 
antibiotics has been reported in some of the studies (2, 
3). This prospective study was therefore undertaken 
to  determine  currently  prevalent  antibiogram  of 
coagulase  negative  staphylococci  isolated  from 
various clinical specimens obtained from inpatients 
of a tertiary care hospital.
MATERIALS  AND  METHODS
A total of 300 CNS strains, isolated from various 
clinical  specimens  between  January  2008  and   
December  2009,  were  processed  in  Department 
of  Microbiology,  Government  Medical  College  in 
Amritsar. The strains selected in this study had the 
potential of being clinically significant on the basis of 
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included the isolates from blood, pus (sole organism 
or  in  moderate  to  heavy  amounts),  urine  (Greater 
than 105 organisms per ml), intravenous catheter tips 
(greater than 15 colonies), ascetic fluid and synovial 
fluid. All  the  blood  cultures  were  from  long  term 
admitted  or  seriously  compromised  patients  with 
indwelling intravenous catheters. All the isolates were 
identified  by  standard  procedures  (Gram  staining, 
catalase test, slide and tube coagulase test) and were 
subjected to speciation. The tests, which were simple, 
inexpensive and easy to perform, were selected from 
the scheme of Kloos and Schleifer (1).
All the 300 isolates were subjected to antibiotic 
sensitivity  testing  by  Kirby  Bauer  Disc  diffusion 
method  (4).  The  antimicrobial  agents  used  were 
penicillin  (10  IU/disc),  erythromycin  (15  μg/disc), 
ciprofloxacin (5 μg/disc), norfloxacin (10 μg/disc), 
nitrofurantoin (300 μg/disc), gentamicin (10 μg/disc), 
amikacin  (30  μg/disc),  vancomycin  (30  μg/disc), 
teicoplanin (30 μg/disc) and linezolid (30 μg/disc) (4). 
Methicillin  resistance  was  studied  by  observing 
minimum  inhibitory  concentration  of  oxacillin  by 
macrobroth diluition method and E (epsilometer) test 
(Hi Comb) (4, 5). 
Oxacillin MIC test. Serial dilutions of oxacillin 
(0.25-256  µg/ml)  were  prepared  in  Muller  Hinton 
broth  (Hi  Media,  Mumbai,  India)  with  added  2% 
NaCl. The  inoculum  was  prepared  by  diluting  0.5 
McFarland  suspension  to  the  concentration  of  105 
CFU/ml. The tubes were inoculated and incubated at 
35°C for 24 hours.  All isolates with MIC of   ≥  0.5 µg/ml 
were taken as resistant and  ≤  0.25 µg/ml as sensitive. 
Two tubes, one growth control tube with no oxacillin, 
and one sterility control tube with no inoculum were 
also incorporated in the tests. Staphylococcus aureus 
ATCC 29213, was used as a reference strain (4, 5).
E Test for oxacillin. The E-test (Hi Comb) was 
performed as per manufacturer’s instructions. An ellip-   
tical zone of inhibition was obtained after incubation 
and MIC was read where ellipse intersected the strip. 
Determination of MIC for vancomycin. Suscepti-
bility to vancomycin was determined by broth dilution 
method. Serial dilutions of vancomycin (0.5-128 µg/
ml) were prepared in Muller Hinton broth (Hi media, 
Mumbai).  The  inoculum  was  prepared  by  diluting 
0.5 McFarland suspension to the concentration of 105 
CFU/ml. The tubes were inoculated and incubated 
at 35°C for 24 hours. Staphylococcu, aureus, ATCC 
29213  and  Entercoccus  faecalis,  ATCC  29212, 
were used as vancomycin susceptible controls and 
E. faecalis 51299 as vancomycin resistant control. 
Readings were taken as per the guidelines of CLSI. 
Isolates with MIC  ≤  2 µg/ml were taken as susceptible, 
MIC = 4-8 µg/ml as intermediate, and MIC ≥ 16µg/
ml as resistant (4-6).
Vancomycin screen agar test. Brain heart infusion 
agar (Hi Media, Mumbai) plates containing 6µg/ml 
of  vancomycin  were  used  for  vancomycin  screen 
agar. The plates were inoculated with the test strain 
from the standard inoculum and incubated at 35°C for 
24 hours. Any visible growth indicated resistance. S. 
aureus, ATCC 29213, was used as a reference strain 
(4, 6).
RESULTS
Of  300  strains  of  CNS  studied,  139  (46.33%) 
were isolated from blood followed by 73 from pus 
(24.33%), 67 (22.33%) from urine, 17 (5.7%) from 
catheter  tips  and  2  (0.6%)  each  from  ascetic  and 
synovial fluids. S. epidermidis was the predominant 
species (n = 162, 54%) and was most frequently 
isolated from all the specimens except urine. The 
second most common species was S. hemolyticus (n 
= 120, 40%) and its commonest source of isolation 
was urine (n = 50, 41.66%). The other species of 
CNS identified were S. warneri  (n = 8, 2.67%), S. 
saprophyticus (n = 7, 2.33%) and S. cohnii  (n = 3, 
1.10%). 
All  300  isolates  were  found  to  be  uniformly 
susceptible to linezolid , vancomycin and teicoplanin. 
Resistance to penicillin was 100% and was followed 
by  that  of  ciprofloxacin  (36.3%),  norfloxacin 
(34.3%), gentamicin (34%), nitrofurantoin (29.9%), 
erythromycin (27.9%) and amikacin (22.7%). Study 
of Oxacillin MIC showed that of the 300 strains, 
144 (48 %) were sensitive  to oxacillin with MIC ≤ 
0.25 µg/ml and 156 (52%) were resistant with MIC 
≥ 0.5 µg/ml. MIC of 156 resistant isolates ranged 
between 0.5 µg/ml to 32 µg/ml. Methicillin resistant 
CNS (MRCNS) showed higher level of resistance 
to other antimicrobial agents studied as compared 
to methicillin sensitive CNS (MSCNS) (Table 1). 
All the study isolates failed to grow on vancomycin 
screen agar and their MIC value for vancomycin was 
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DISCUSSION
Our study identified five different species/groups 
of  CNS  namely  S.  epidermidis,  S.  haemolyticus, 
S.  saprophyticus,  S.  warneri  and  S.  cohnii.  S. 
epidermidis  was  the  commonest  (54%)  followed 
by S. haemolyticus (40%) which was also the most 
frequent isolate from blood cultures and intravenous 
catheter tips which is  similar to the findings of other 
authors and signifies its importance as an agent of 
nosocomial  bacteremia  and  catheter  related  sepsis 
(1, 7, 8). S. haemolyticus was the predominant isolate 
from urine specimens in our study (50 of 67, 74.62%). 
In the study of Chaudary et al., it’s isolation rate from 
urine specimens was 84.1%. Other studies have also 
reported  this  species  as  an  important  pathogen  of 
nosocomial urinary tract infections (9).
Antibiotic resistant CNS has emerged as a major 
cause of morbidity and mortality in hospital setting 
during the last decade. Majority of CNS recovered 
in  our  study  also  showed  multidrug  resistance  but 
the susceptibility pattern was at variance with that 
reported in some other studies. Many studies from 
different parts of the world have reported presence of 
multidrug resistance in CNS (10, 11). Also from India, 
many  authors  have  reported  multidrug  resistance 
in coagulase negative staphylococci (1, 7, 12, 13). 
Patricia et al. have reported 61% of their study isolates 
to be multidrug resistant (14). This could be because 
of different protocols and panels of antibiotics used in 
various hospitals and perhaps also due to differential 
clonal expression and drug pressure in the community 
(15).
In the present study, the prevalence of methicillin 
resistance  among  CNS  in  our  hospital  was  52% 
which is less than that reported from Delhi (62.7%) 
but more than that from Lucknow (38%) (7, 16). In 
an earlier study (1997-98) conducted in our hospital, 
CNS showed 20.8% methicillin resistance (15). This 
increase in incidence of MRCNS in our hospital in 
last  one  decade  is  statistically  significant  and  has 
become a potential problem.
A  comparison  between  antibiotics  sensitivity 
patterns  of  MRCNS  and  MSCNS  of  our  study 
revealed that MRCNS had higher level of resistance 
to  many  antimicrobials  as  compared  to  MSCNS. 
Similar findings showing higher antibiotic resistance 
among MRCNS have been reported by many authors 
(7). The  difference  was  statistically  significant  for 
ciprofloxacin, gentamicin and amikacin (p < 0.05). 
Oliveria  et  al.  found  this  difference  statistically 
significant  for  ciprofloxacin  and  gentamicin  (p  ≤ 
0.05) (17). 
All the MRCNS in our study were susceptible to 
glycopeptides  (vancomycin  and  teicoplanin)  which 
corroborates the findings of many authors (7, 8, 10, 
12, 15, 16). However, there are reports of decreased 
susceptibility to frank resistance to vancomycin and 
teicoplanin from our country (6, 9, 18). One hundred 
percent susceptibility of strains isolated our study to 
Antibiotics MRCNS 
% Resistance
MSCNS
% Resistance
p value Statistical significance
Penicillin 100 100 - -
Ciprofloxacin 47.6 24.1 < 0.05 Significant
Gentamicin 45.3 21.6 < 0.05 Significant
Norfloxacin* 44.8 27.5 > 0.05 Non significant
Nitrofurantoin* 41.3 20.6 > 0.05 Non significant
Erythromycin# 31.6 23   > 0.05 Non significant
Amikacin 31.5 13 < 0.05 Significant
Vancomycin 0 0 - -
Linezolid 0 0 - -
Table . Statistical analysis of antibiotic resistance pattern of  MRCNS and MSCNS.
* = used only in urine isolates, #= not used in urine isolates
MRCNS = Methicillin resistant coagulase negative staphylococci 
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glycopeptides suggests prudent use and continuous 
monitoring of MIC levels so that we may not fall 
back into pre-antibiotic era. 
It is thus concluded that isolation of CNS and their 
antibiotic  susceptibility  pattern  should  be  regarded 
with all seriousness in clinical practice and clinical 
epidemiology  because by being resistant to multiple 
antibiotics (methicillin resistant CNS, in particular), 
their prevalence not only limits the treatment options 
but also act as a reservoir of drug resistance genes. 
MRCNS  are  emerging  nosocomial  pathogens  and 
every effort should be made for prevention and control 
of  infections  caused  by  MRCNS  which  depends 
on  practices  of  effective  hospital  infection  control 
measures and minimization of risk factors by doing 
regular surveys of health care providers to detect and 
treat the CNS carriers so that they do not transmit the 
CNS to the patients.
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